Research Topics
Genomes and GenesSpecies | Farbod DarvishianSummaryAffiliation: New York University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patientsJessie Z Yu
Department of Dermatology, New York University School of Medicine, New York, NY, USA
J Transl Med 6:70. 2008..In this study, we examined both IGFBP-3 and -4 levels in tissues and sera of melanoma patients representing different stages of melanoma progression...
Atypia on breast core needle biopsies: reproducibility and significanceFarbod Darvishian
Department of Pathology, New York University Medical Center, 530 First Avenue SK7N, New York, NY 10016, USA
Ann Clin Lab Sci 39:270-6. 2009..Strict adherence to the diagnostic criteria and tutorial sessions can help pathologists to achieve substantial agreement in interpreting atypia on breast core needle biopsies...
Histology-specific microRNA alterations in melanomaLaura Poliseno
The Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA
J Invest Dermatol 132:1860-8. 2012..Our data support a molecular classification in which SSM and NM are two molecularly distinct phenotypes. Therapeutic strategies that take into account subtype-specific alterations might improve the outcome of melanoma patients...
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survivalJan Zakrzewski
The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine and New York University Cancer Institute, New York, New York, USA
Cancer 117:1711-20. 2011..In the current study, the authors attempted to identify primary tumor characteristics and clinical features predictive of B-Met development and post-B-Met survival...
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph nodeMichelle W Ma
Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA
Mod Pathol 25:1000-10. 2012..025) and melanoma-specific (P=0.014) survival. Our results support an assessment of local immune profiles in both the primary tumor and sentinel lymph node to help guide therapeutic decisions...
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral siteMichelle W Ma
Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA
Neuro Oncol 14:849-58. 2012..Studies are needed to better understand the biological factors driving this phenotype at the time of primary melanoma diagnosis and to determine its clinical implications...
Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34Amy E Rose
Department of Dermatology, New York University School of Medicine, New York, NY, USA
Am J Surg Pathol 35:1441-9. 2011..27-3.18; P=0.003] and OS (HR, 2.08; 95% CI: 1.25-3.46; P=0.005). Results show that D2-40 and CD34 increase the detection of LVI in primary melanoma and that cases missed by routine histology have prognostic relevance...
A high proliferative index of recurrent melanoma is associated with worse survivalTing J Tu
The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, NY 10016, USA
Oncology 80:181-7. 2011..We examined the prognostic relevance of recurrent tumor proliferation...
Single versus multiple primary melanomas: old questions and new answersCharlotte Hwa
Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA
Cancer 118:4184-92. 2012....
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progressionAmy E Rose
Department of Dermatology, New York University School of Medicine, New York, New York, USA
Cancer Res 71:2561-71. 2011..Furthermore, our data suggest a role for altered regulation of metabolism-related genes as a possible cause of the different clinical behavior of SSM and NM...
Clinical relevance of SKP2 alterations in metastatic melanomaAmy E Rose
Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA
Pigment Cell Melanoma Res 24:197-206. 2011..Copy number gain is a major contributing mechanism of SKP2 overexpression in metastatic melanoma. Results may have implications for the development of therapeutics that target SKP2...
Melanoma MicroRNA signature predicts post-recurrence survivalMiguel F Segura
Department of Pathology, New York University School of Medicine, New York, New York, USA
Clin Cancer Res 16:1577-86. 2010..To identify a melanoma microRNA (miRNA) expression signature that is predictive of outcome and then evaluate its potential to improve risk stratification when added to the standard-of-care staging criteria...
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survivalDusan Bogunovic
Cancer Institute and Department of Pathology, New York University Langone Medical Center, New York, NY 10016, USA
Proc Natl Acad Sci U S A 106:20429-34. 2009....
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanomaMolly Yancovitz
Department of Dermatology, New York University Langone Medical Center, New York, New York, United States of America
PLoS ONE 7:e29336. 2012....
The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanomaChanh Huynh
Department of Medicine, New York University School of Medicine, New York, New York, United States of America
PLoS ONE 6:e25264. 2011..Finally, increased gene expression of NOTCH signaling components correlated with shorter post recurrence survival in metastatic melanoma cases. Our data support NOTCH inhibition as a promising therapeutic strategy against melanoma...
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasisAvital Gaziel-Sovran
Department of Pathology, New York University Medical Center, NY 10016, USA
Cancer Cell 20:104-18. 2011..These data support a key role of miR-30b/30d and GalNAc transferases in metastasis, by simultaneously promoting cellular invasion and immunosuppression...
Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literatureAmber A Guth
Department of Surgery, NYU School of Medicine, New York City, New York, USA
Breast J 14:335-9. 2008..In this series, 7% of patients had macrometastatic disease, and two patients (5%) had itc only. Axillary staging is indicated, and SNB is appropriate for the identification of axillary metastatic disease...
Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literatureJoan Cangiarella
Department of Pathology, New York University School of Medicine, New York, USA
Arch Pathol Lab Med 132:979-83. 2008..Due to the debate over the significance of these lesions and the small number of cases reported in the literature, the treatment for lobular neoplasia diagnosed by percutaneous core biopsy (PCB) remains controversial...
Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancerDeborah Silvera
Department of Microbiology, New York University School of Medicine, New York, 10016, USA
Nat Cell Biol 11:903-8. 2009..Overexpression of eIF4GI promotes formation of IBC tumour emboli by enhancing translation of IRES-containing p120 mRNAs. These findings provide a new understanding of translational control in the development of advanced breast cancer...
Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institutionChristopher G Przybycin
Department of Pathology, Urology Service, Memorial Sloan Kettering Cancer Center New York, NY 10065, USA
Am J Surg Pathol 35:962-70. 2011..On the basis of this long follow-up on a large number of cases, chromophobes seem to have better clinical outcomes than those reported for clear cell and papillary RCCs...
Changes in the presentation of nodular and superficial spreading melanomas over 35 yearsMelanie A Warycha
Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA
Cancer 113:3341-8. 2008..To better define the clinical behavior of NMs, the authors compared their clinical and histopathologic features to those of SSMs at their institution, a tertiary referral center, over 3 decades...
Intraparenchymal leiomyoma of the breast: a case report and review of the literatureLauren Ende
Dept of Pathology, NYU School of Medicine, New York, NY 10016, USA
Ann Clin Lab Sci 37:268-73. 2007..In addition, we review the literature on this uncommon breast neoplasm...
Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40Jordan Laser
New York University School of Medicine, New York, NY 10016, USA
Ann Clin Lab Sci 38:99-104. 2008..In conclusion, D2-40 antibody staining may be useful as an adjunct in detecting LVI in invasive lobular carcinoma, especially in node-negative patients with the classic variant of invasive lobular carcinoma...
Extramedullary hematopoiesis in breast after neoadjuvant chemotherapy for breast carcinomaJun Wang
Department of Pathology, New York University Medical Center, New York, NY 10016, USA
Ann Clin Lab Sci 36:475-8. 2006..To our knowledge, the association of EMH and neoadjuvant chemotherapy has not been previously reported...
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanomaElnaz F Firoz
Department of Dermatology, New York University School of Medicine, New York, New York, USA
Clin Cancer Res 15:2573-80. 2009..To investigate this difference, we examined the association among MDM2 SNP309, age at diagnosis, and gender among melanoma patients...
Immunoreactivity of p16 in anal cytology specimens: histologic correlationFarbod Darvishian
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 108:66-71. 2006..CONCLUSIONS: The presence of p16 immunoreactivity is a good predictor of dysplasia in anal specimens. However, the sensitivity and specificity of this marker are not high...
Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic casesFarbod Darvishian
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Am J Surg Pathol 28:1568-78. 2004..Our clinical and immunohistochemical data also support the concept that there is a group of endometrial adenocarcinomas composed of tubular glands that are indeed serous carcinomas...
Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesionsFarbod Darvishian
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 102:355-61. 2004..The authors characterized the cytologic features of myoepithelial cell-rich lesions in an attempt to define the criteria that facilitate distinction between benign and malignant tumors...
Carcinosarcoma of the pancreas: a case report and review of the literatureFarbod Darvishian
Department of Pathology, North Shore University Hospital, Manhasset, NY 11030, USA
Arch Pathol Lab Med 126:1114-7. 2002..To our knowledge, this carcinosarcoma is the seventh reported case of a primary pancreatic neoplasm with mixed carcinomatous and sarcomatous elements...
